Delivery Order SPE2DB22D2206-SPE2DB25FHL16
Award Date
6/13/25
Potential Completion Date
6/16/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of glycopyrrolate 0.2 mg/ml vial, 2 ml, a medication used to treat certain medical conditions. The contract has a ceiling value of $4,591.37 and a completion date of July 22, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a...
This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,341.26, is for the supply of glycopyrrolate 0.2 mg/ml vials (20 ml) to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of May 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Glycopyrrolate 0.2 mg/ml vial, 5 ml, a medication used for various medical purposes. The contract has a ceiling value of $1,266.99 and is a firm fixed-price contract with a period of performance through May 8, 2025. The contract is not set aside for any specific business category....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of GLYCOPYRROLATE 0.2 MG/ML VIALML, with a ceiling value of $2,310.31 and an ultimate completion date of June 12, 2025. This is a Firm Fixed Price delivery order contract, without any set-aside designation, indicating open competition....
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,108,712 units of the medication glycopyrrolate 0.2 mg/ml in 5 ml vials. The contract has a ceiling value of $4,674.96 and a period of performance through March 29, 2024. This delivery order contract was issued under a larger, single-award indefinite delivery contract (IDC) that Amerisourcebergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,254,915 units of the drug Glycopyrrolate 1 mg/5 ml vial, 5 ml, with a ceiling value of $1,495.28. It is a firm fixed-price delivery order contract with a completion date of September 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,241.53 fixed-price contract is for the delivery of Glycopyrrolate 0.2 mg/ml vial, a medication used to treat certain conditions. The contract has a completion date of June 12, 2025 and is not set aside for any specific business category. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of GLYCOPYRROLATE 4 MG/20 ML VIAL 20ML, a critical medical product, with a ceiling value of $1,338.90 and a performance period through September 25, 2023. This Delivery Order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract valued at $3,925.09 for the supply of GLYCOPYRROLATE INJECT. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLYCOPYRROLATE 0.2 MG/ML VIALML, a pharmaceutical product, with a ceiling value of $1,035.90 and a completion date of May 30, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...